Pimasertib Versus Dacarbazine in Patients With UnresectableNRAS-Mutated Cutaneous Melanoma: Phase II, Randomized, Controlled Trial with Crossover

Lebbe, Celeste; Dutriaux, Caroline; Lesimple, Thierry; Kruit, Willem; Kerger, Joseph; Thomas, Luc; Guillot, Bernard; de Braud, Filippo; Garbe, Claus; Grob, Jean-Jacques; Loquai, Carmen; Ferraresi, Virginia; Robert, Caroline; Vasey, Paul; Conry, Robert; Isaacs, Richard; Espinosa, Enrique; Schueler, Armin; Massimini, Giorgio; Dreno, Brigitte

Publikationsdienste
→
Universitätsbibliographie
→
4 Medizinische Fakultät
→
Dokumentanzeige

« zurück

Pimasertib Versus Dacarbazine in Patients With UnresectableNRAS-Mutated Cutaneous Melanoma: Phase II, Randomized, Controlled Trial with Crossover

Autor(en):

Lebbe, Celeste; Dutriaux, Caroline; Lesimple, Thierry; Kruit, Willem; Kerger, Joseph; Thomas, Luc; Guillot, Bernard; de Braud, Filippo; Garbe, Claus; Grob, Jean-Jacques; Loquai, Carmen; Ferraresi, Virginia; Robert, Caroline; Vasey, Paul; Conry, Robert; Isaacs, Richard; Espinosa, Enrique; Schueler, Armin; Massimini, Giorgio; Dreno, Brigitte

Tübinger Autor(en):

Garbe, Claus

Erschienen in:

Cancers (2020), Bd. 12 (7), Article 1727

Verlagsangabe:

Mdpi

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.3390/cancers12071727

ISSN:

2072-6694